SCHEMBL29608968

SCHEMBL29608968

CCCn1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2F)cn1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 2/20 0.60
▸ CSF1R P07333 5/20 0.57
▸ CDK4 P11802 5/20 0.57
▸ CDK6 Q00534 5/20 0.57
▸ PAK1 Q13153 1/20 0.55
▸ JAK2 O60674 10/20 0.53
▸ TYK2 P29597 9/20 0.53
▸ JAK1 P23458 6/20 0.53
▸ JAK3 P52333 4/20 0.52
▸ PIK3CD O00329 1/20 0.52
▸ FLT3 P36888 2/20 0.51
▸ STAT3 P40763 1/20 0.51
▸ BRD4 O60885 1/20 0.51
▸ BTK Q06187 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24663774 1.00 AXL (0.60) AXLCSF1RCDK4CDK6PAK1
SCHEMBL24664549 0.95 AXL (0.58) AXLCSF1RCDK4CDK6PAK1
SCHEMBL29608022 0.95 AXL (0.58) AXLCSF1RCDK4CDK6PAK1
SCHEMBL29608267 0.93 CDK4 (0.53) AXLCSF1RCDK4CDK6PAK1
SCHEMBL24663772 0.93 CDK4 (0.53) AXLCSF1RCDK4CDK6PAK1
SCHEMBL24663778 0.85 FLT3 (0.53) AXLCSF1RCDK4CDK6PAK1
SCHEMBL29608982 0.84 CDK6 (0.67) AXLCSF1RCDK4CDK6JAK2
SCHEMBL24664426 0.84 CDK6 (0.67) AXLCSF1RCDK4CDK6JAK2
SCHEMBL24663787 0.84 JAK2 (0.51) CSF1RCDK4CDK6JAK2TYK2
SCHEMBL29607128 0.84 JAK2 (0.51) CSF1RCDK4CDK6JAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423750-B 2, 4-Disubstituted pyrimidine derivative, preparation method and application thereof 成都赜灵生物医药科技有限公司 2024-04-19 — — CN disclosed
CN-114423750-A 2, 4-disubstituted pyrimidine derivative and preparation method and application thereof 成都赜灵生物医药科技有限公司 2022-04-29 — — CN disclosed
Send feedback